What Orchestra BioMed Holdings, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 9 |
| Sells | 3 | 5 |
| Total trades | 22 | 56 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,000 | 1,252,032 |
| Disposed | 14,838 | 24,719 |
| Net activity | −12,838 | +1,227,313 |
Common stock only — 46 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sherman Darren | See Remarks | Sep 01 | Disclosed 10b5-1 sale · S | −15,000 | $4.94 | −$74.1K | 1,134,402 |
| Taylor Andrew Lawrence | Chief Financial Officer | Aug 26 | Withheld — tax / exercise cost · F | −3,076 | $5.26 | −$16.2K | 589,989 |
| Sherman Darren | See Remarks | Aug 26 | Open-market buy · P | +2,000 | $5.33 | +$10.7K | 2,000 |
| Sherman Darren | See Remarks | Aug 26 | Withheld — tax / exercise cost · F | −4,925 | $5.26 | −$25.9K | 1,149,402 |
| Aiello Joshua | Principal Accounting Officer | Aug 26 | Withheld — tax / exercise cost · F | −203 | $5.26 | −$1.07K | 18,441 |
| Cleary Chris | Director | Aug 12 | Withheld — tax / exercise cost · F | −4,238 | $4.42 | −$18.7K | 29,153 |
| Fain Eric S | Director | Aug 12 | Withheld — tax / exercise cost · F | −5,145 | $4.42 | −$22.7K | 99,630 |
| Pacitti David | Director | Aug 12 | Withheld — tax / exercise cost · F | −3,761 | $4.42 | −$16.6K | 54,750 |
| Mack John Prosper | Director | Aug 12 | Withheld — tax / exercise cost · F | −4,885 | $4.42 | −$21.6K | 66,544 |
| Sherman Darren | See Remarks | Aug 03 | Disclosed 10b5-1 sale · S | −15,000 | $4.09 | −$61.4K | 1,154,327 |
| Sherman Darren | See Remarks | Jul 01 | Disclosed 10b5-1 sale · S | −15,000 | $4.27 | −$64.1K | 1,169,327 |
| Mack John Prosper | Director | Jun 24 | Withheld — tax / exercise cost · F | −3,510 | — | — | 71,429 |
| Cleary Chris | Director | Jun 24 | Withheld — tax / exercise cost · F | −3,510 | — | — | 33,391 |
| Fain Eric S | Director | Jun 24 | Withheld — tax / exercise cost · F | −4,261 | — | — | 104,775 |
| Pacitti David | Director | Jun 24 | Withheld — tax / exercise cost · F | −3,784 | — | — | 58,511 |
| Mack John Prosper | Director | Jun 23 | Grant / award · A | +34,653 | — | — | 74,939 |
| Yanchik Connealy Pamela | Director | Jun 23 | Grant / award · A | +17,327 | — | — | 66,038 |
| Fain Eric S | Director | Jun 23 | Grant / award · A | +17,327 | — | — | 109,036 |
| Pacitti David | Director | Jun 23 | Grant / award · A | +17,327 | — | — | 62,295 |
| Hochman David P | See Remarks | Jun 10 | Withheld — tax / exercise cost · F | −3,283 | $4.02 | −$13.2K | 436,199 |
Loading...
